Ascelia Pharma AB (OSTO:ACE)
kr 9.23 -0.17 (-1.81%) Market Cap: 311.58 Mil Enterprise Value: 303.85 Mil PE Ratio: 0 PB Ratio: 4.95 GF Score: 20/100

Q4 2023 Ascelia Pharma AB Earnings Presentation Transcript

Feb 09, 2024 / 09:00AM GMT
Release Date Price: kr8.76 (-4.78%)
Operator

Presentation
Feb 09, 2024 / 09:00AM GMT

=====================
Corporate Participants
=====================
* Magnus Corfitzen
Ascelia Pharma AB - CEO
* Andreas Norlin
Ascelia Pharma AB - Chief Scientific Officer
* Julie Waras Brogren
Ascelia Pharma AB - Deputy CEO & Chief Commercial Officer

=====================
Conference Call Participants
=====================
* Ludvig Svensson
Carnegie Investment Bank - Analyst
* Johan Unnerus
Redeye AB - Analyst

=====================

Magnus Corfitzen
Ascelia Pharma AB - CEO

This call is being recorded. Welcome to Ascelia Pharma Q4 2023 report presentation. (Operator Instructions)

Now, I will hand the conference over to CEO, Magnus Corfitzen; CSO, Andreas Norlin; Deputy CEO, Finance, Investor Relations, and Commercial, Julie Waras Brogren. Please go ahead.

-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot